The Food and Drug Administration (FDA) recently approved Keytruda (pembrolizumab) plus chemoradiotherapy (CRT) for the treatment of patients with stages 3 to 4A cervical cancer. The first approval of ...
The Chosun Ilbo on MSN
MSD Korea CEO vows continued R&D leadership, Keytruda expansion
MSD is a company that is ‘serious about science.’ In 2024, its global research and development investment reached $17.9 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback